Replies to post #392646 on NorthWest Biotherapeutics Inc (NWBO)

[anders2211]

We are going in circles you have been proven to be wrong so many times its getting tiresome. Again from the last 10K


We rely at present AS IN NOW on third-party contract manufacturerS PLURAL. As a result, we may be at risk for issues with manufacturing agreementS PLURAL, capacity limitations and/or supply disruptions, and/or issues with product equivalency.

We rely upon specialized contract manufacturerS PLURAL, operating in specialized GMP (clean room) manufacturing facilitieS PLURAL, to produce all of our DCVax products. We have worked with several such manufacturerS PLURAL, in several different locations (Swanston is last time I checked ONE location), during various periods of our clinical trials and our compassionate treatment programs, including Advent BioServices, Cognate BioServices and the Fraunhofer Institute.

Jeeez how well is your English?

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=164355874

[hyperopia]

If it’s so clear, then why do you have it so wrong? Northwest Bio has not shut down any programs nor has it made any payments for it.

Cognate was contracted to manufacture for the clinical trials, so understandably, the focus in the SEC filings was on them. The current focus is on preparations for commercial production at Sawston, and Advent has been contracted to perform that task, so the focus in the SEC documents is on them. I believe that Northwest Bio will use both contract manufacturers for commercial production, but is waiting to sign commercial manufacturing contracts until the comparability studies on the Flaskworks’ equipment has produced actionable results.